Featured Research

from universities, journals, and other organizations

Why Predicting The Next Influenza Pandemic Is So Difficult -- And How Scientists Can Prepare

Date:
May 9, 2007
Source:
NIH/National Institute of Allergy and Infectious Diseases
Summary:
In planning for a future influenza pandemic, most experts agree that two things are known for certain -- there will be another pandemic someday, and nobody can predict when. In a recent article, scientists at NIH discuss why predicting the next pandemic is so difficult and outline steps that can be taken to better understand the behavior of the virus.

In planning for a future influenza pandemic, most experts agree that two things are known for certain--there will be another pandemic someday, and nobody can predict when. In a commentary in the May 9, 2007 issue of the Journal of the American Medical Association, scientists at the National Institutes of Health discuss why predicting the next pandemic is so difficult and outline steps that can be taken to better understand the behavior of the virus.

Drawing upon the lessons of past pandemics, the authors analyze the significance of the highly pathogenic avian influenza strain H5N1, which has spread among bird populations and infected hundreds of humans in the last decade. In preparing for the next influenza pandemic, however, the authors argue that researchers and public health officials should not focus solely on H5N1 strains, because the next pandemic might be caused by a different influenza virus.

Instead, research efforts should go beyond H5N1 and focus broadly on influenza viruses. This entails improving our knowledge of the basic biological and ecological means by which influenza A viruses infect birds; enhancing surveillance of infected animals and the circulation of influenza virus globally; understanding how the virus evolves and jumps from birds and other animals to humans; finding new approaches to vaccine design and vaccination; and developing new antivirals and diagnostics.

Such broad activities can also help combat seasonal influenza, which is a major public health concern in the United States, accounting for an estimated 36,000 deaths and 200,000 hospitalizations each year.

Article: "The next influenza pandemic: can it be predicted?" by J Taubenberger, D Morens and A Fauci. JAMA DOI: 10.1001/jama.297.18.2025 (2007).


Story Source:

The above story is based on materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute of Allergy and Infectious Diseases. "Why Predicting The Next Influenza Pandemic Is So Difficult -- And How Scientists Can Prepare." ScienceDaily. ScienceDaily, 9 May 2007. <www.sciencedaily.com/releases/2007/05/070509073514.htm>.
NIH/National Institute of Allergy and Infectious Diseases. (2007, May 9). Why Predicting The Next Influenza Pandemic Is So Difficult -- And How Scientists Can Prepare. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/05/070509073514.htm
NIH/National Institute of Allergy and Infectious Diseases. "Why Predicting The Next Influenza Pandemic Is So Difficult -- And How Scientists Can Prepare." ScienceDaily. www.sciencedaily.com/releases/2007/05/070509073514.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins